DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.69% | -30.30% | -10.63% | -37.39% | -50.40% |
| Total Depreciation and Amortization | 300.00% | 0.00% | 0.00% | 80.00% | -70.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 58.92% | 4.47% | 245.68% | 259.82% | 327.27% |
| Change in Net Operating Assets | 303.12% | 473.42% | -99.75% | -19.75% | -214.77% |
| Cash from Operations | -6.79% | -27.04% | -20.69% | -46.53% | -68.13% |
| Capital Expenditure | 50.00% | 33.33% | 14.29% | -77.78% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.00% | -131.75% | 53.51% | -361.80% | 89.25% |
| Cash from Investing | -7.97% | -131.92% | 53.60% | -361.34% | 89.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 0.00% | 33.33% | 0.00% | 0.00% |
| Issuance of Common Stock | -17.18% | 346.81% | 9,686.18% | 25,290.48% | -98.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.01% | 358.24% | 9,975.83% | 25,536.59% | -98.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.83% | -2,372.25% | 1,211.00% | 92.12% | -87.30% |